February 10, 2020 / 9:57 PM / 11 days ago

BRIEF-Logicbio Therapeutics Provides Update On FDA Review Of Investigational New Drug Application For LB-001 For Methylmalonic Acidemia

Feb 10 (Reuters) - LogicBio Therapeutics Inc:

* LOGICBIO THERAPEUTICS PROVIDES UPDATE ON FDA REVIEW OF INVESTIGATIONAL NEW DRUG APPLICATION FOR LB-001 FOR METHYLMALONIC ACIDEMIA

* LOGICBIO THERAPEUTICS INC - U.S. FDA HAS PLACED A CLINICAL HOLD ON IND SUBMISSION FOR LB-001 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below